In-Person US FDA Meetings Returning? Agency Will Support Those Events At HQ

 
• By Derrick Gingery

A workshop broadcast from White Oak was a shift from the fully virtual meetings held since the height of the COVID-19 pandemic and may be a step toward once again staging public events there.

FDA biosimilar workshop panel discussion
The audience was virtual, but many FDA speakers attended the biosimilars workshop in person. • Source: Screenshot of FDA broadcast

More from US FDA

More from Agency Leadership